ES555670A0 - Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas. - Google Patents
Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas.Info
- Publication number
- ES555670A0 ES555670A0 ES555670A ES555670A ES555670A0 ES 555670 A0 ES555670 A0 ES 555670A0 ES 555670 A ES555670 A ES 555670A ES 555670 A ES555670 A ES 555670A ES 555670 A0 ES555670 A0 ES 555670A0
- Authority
- ES
- Spain
- Prior art keywords
- hexahidroarilquinolizinas
- substituted
- procedure
- preparation
- substituted hexahidroarilquinolizinas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74060985A | 1985-06-03 | 1985-06-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8707729A1 ES8707729A1 (es) | 1987-08-16 |
| ES555670A0 true ES555670A0 (es) | 1987-08-16 |
Family
ID=24977288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES555670A Expired ES8707729A1 (es) | 1985-06-03 | 1986-06-03 | Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0204254A3 (es) |
| JP (1) | JPS6236380A (es) |
| KR (1) | KR900004588B1 (es) |
| AU (1) | AU576962B2 (es) |
| DK (1) | DK258086A (es) |
| ES (1) | ES8707729A1 (es) |
| GR (1) | GR861403B (es) |
| IL (1) | IL78918A (es) |
| NZ (1) | NZ216283A (es) |
| PT (1) | PT82643B (es) |
| ZA (1) | ZA864096B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ221485A (en) * | 1986-08-28 | 1991-04-26 | Merck & Co Inc | Hexahydroarylquinolizine derivatives and pharmaceutical compositions |
| US4831035A (en) * | 1986-08-28 | 1989-05-16 | Merck & Co., Inc. | Substituted hexahydroarylquinolizines |
| CA1321751C (en) * | 1989-02-21 | 1993-08-31 | Eugene C. Crichlow | Mechanism mediating ruminal stasis in ruminal lactic acidosis |
| ATE374773T1 (de) | 2002-04-03 | 2007-10-15 | Orion Corp | Polycyclische verbindungen als potenten alpha2- adrenoceptor antagonisten |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1524953A (fr) * | 1962-03-26 | 1968-05-17 | Konink Pharmaceutische Fabrike | Procédé de préparation des dérivés de la quinolizine |
-
1986
- 1986-05-23 NZ NZ216283A patent/NZ216283A/xx unknown
- 1986-05-26 PT PT82643A patent/PT82643B/pt not_active IP Right Cessation
- 1986-05-26 IL IL78918A patent/IL78918A/xx unknown
- 1986-05-27 EP EP86107199A patent/EP0204254A3/en not_active Withdrawn
- 1986-05-29 GR GR861403A patent/GR861403B/el unknown
- 1986-06-02 DK DK258086A patent/DK258086A/da not_active Application Discontinuation
- 1986-06-02 ZA ZA864096A patent/ZA864096B/xx unknown
- 1986-06-02 AU AU58260/86A patent/AU576962B2/en not_active Ceased
- 1986-06-03 ES ES555670A patent/ES8707729A1/es not_active Expired
- 1986-06-03 JP JP61127380A patent/JPS6236380A/ja active Pending
- 1986-06-03 KR KR1019860004394A patent/KR900004588B1/ko active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ES8707729A1 (es) | 1987-08-16 |
| ZA864096B (en) | 1987-01-28 |
| IL78918A (en) | 1990-06-10 |
| IL78918A0 (en) | 1986-09-30 |
| EP0204254A2 (en) | 1986-12-10 |
| GR861403B (en) | 1986-09-26 |
| AU5826086A (en) | 1986-12-11 |
| DK258086A (da) | 1987-02-20 |
| JPS6236380A (ja) | 1987-02-17 |
| AU576962B2 (en) | 1988-09-08 |
| KR900004588B1 (ko) | 1990-06-30 |
| PT82643B (pt) | 1988-03-03 |
| KR870000331A (ko) | 1987-02-17 |
| NZ216283A (en) | 1989-10-27 |
| PT82643A (en) | 1986-06-01 |
| EP0204254A3 (en) | 1988-03-02 |
| DK258086D0 (da) | 1986-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES551249A0 (es) | Un procedimiento para la preparacion de peptidilaminodioles. | |
| ES555834A0 (es) | Un procedimiento para la preparacion de nuevas piranopiridinas. | |
| ES554405A0 (es) | Un procedimiento para la preparacion de derivados de aza-indol. | |
| ES556738A0 (es) | Un procedimiento para la preparacion de nuevos piridazinaminas. | |
| ES553044A0 (es) | Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina. | |
| ES545464A0 (es) | Un procedimiento para la preparacion de tetrahidroftalimidas. | |
| ES540705A0 (es) | Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas. | |
| ES556550A0 (es) | Un procedimiento para la preparacion de androsta -1-4-dien-3,17-dionas. | |
| ES544644A0 (es) | Un procedimiento para la preparacion de derivados de carboxamidoadenosina. | |
| ES556127A0 (es) | Un procedimiento para la preparacion de quinolinas 2-sustituidas. | |
| ES546236A0 (es) | Un procedimiento para la preparacion de derivados de bencimidasol. | |
| ES554983A0 (es) | Un procedimiento para la preparacion de silileteres. | |
| ES552189A0 (es) | Un procedimiento para la preparacion de derivados de piridimilmidazolidiona. | |
| ES540609A0 (es) | Un procedimiento para la preparacion de pirazolo piridinas. | |
| ES540610A0 (es) | Un procedimiento para la preparacion de pirazolopiridinas. | |
| ES544521A0 (es) | Un procedimiento para la preparacion de triazolobenzodiazefinas. | |
| ES546872A0 (es) | Un procedimiento para la preparacion de aminoalcoxibenzopiranonas. | |
| ES552297A0 (es) | Un procedimiento para la preparacion de nuevos derivados de disacaridos o trisacaridos. | |
| ES541781A0 (es) | Un procedimiento para la preparacion de nuevos benzotiopenos. | |
| ES550504A0 (es) | Un procedimiento para la preparacion de derivados de podofilotoxina. | |
| ES553874A0 (es) | Un procedimiento para la preparacion de metanosulfonatos de dioxolano. | |
| ES555369A0 (es) | Un procedimiento para la preparacion de un polialquenoilisocianato. | |
| ES547805A0 (es) | Un procedimiento para la preparacion de nuevos derivados de guanina. | |
| ES554661A0 (es) | Un procedimiento para la preparacion de un hidralizado proteico. | |
| ES553283A0 (es) | Un procedimiento para la preparacion de 2-amino-6-cloropurina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 20000503 |